首页 › 前列腺癌 › 南卡罗来纳州 › Charleston
Charleston SC 前列腺癌临床试验
15项针对 前列腺癌的研究正在 Charleston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
招募中2 期
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Medical University of South Carolina, Charleston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- MUSC Hollings Cancer Center, Charleston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
招募中2 期
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Medical University of South Carolina - Hollings Cancer Center, Charleston
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Medical University of South Carolina, Charleston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Medical University of South Carolina, Charleston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Medical University of South Carolina, Charleston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
招募中观察性研究
- Ralph H. Johnson VA Medical Center, Charleston
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
招募中2 期
- Hollings Cancer Center at Medical University of South Carolina, Charleston
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
招募中2 期
- Medical University of South Carolina Hollings Cancer Center, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中观察性研究欢迎健康志愿者
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 123, Charleston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Medical University of South Carolina, Charleston
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Baltimore, MD43 项研究
- Nashville, TN43 项研究
- Seattle, WA42 项研究
- Washington, DC38 项研究
Charleston的其他研究
- 抑郁症19 项研究
- 卒中18 项研究
- 心力衰竭18 项研究
- 非小细胞肺癌16 项研究
- 创伤后应激障碍16 项研究
- 心血管疾病15 项研究
- 癌症(所有类型)14 项研究
- 头颈鳞状细胞癌14 项研究
- 帕金森病13 项研究
- 间质性肺病13 项研究
- 乳腺癌12 项研究
- 肺癌11 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。